<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Wed, 22 Apr 2026 06:30:47 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/sglt2/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[October 18, 2024. Kidney Facts. Chronic Kidney Disease 1]]></title><description><![CDATA[The use of sodium-glucose transporter (SGLT-2) inhibitors can reduce the progression of chornic kidney disease in diabetics and non-diabetics]]></description><link>http://direct.ecency.com/hive-148441/@ikservices/october-18-2024-kidney-facts-chronic-kidney-disease-1</link><guid isPermaLink="true">http://direct.ecency.com/hive-148441/@ikservices/october-18-2024-kidney-facts-chronic-kidney-disease-1</guid><category><![CDATA[hive-148441]]></category><dc:creator><![CDATA[ikservices]]></dc:creator><pubDate>Sat, 19 Oct 2024 03:14:00 GMT</pubDate><enclosure url="https://images.ecency.com/p/k75bsZMwYNu2L3iBMXq5y7xeiy1isFJsZxnMZSXuXEsxe4ee1cUkGyPXMtaXaAwYCp17FHUCm27ux3JgvB2xihTUbXZrcxS71thhWA8gAYbMYniRsNmpC7iiwwNKChJPHYZX6S9gS3wTzRw443qPpqNKiNoCamKgz?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[August 30, 2023. Glomerular Hyperfiltration and SGLT-2 Inhibitors in Early Diabetes]]></title><description><![CDATA[Article name: The Proximal Tubule in the Pathophysiology of the Diabetic Kidney Link DOI This article was published in the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology]]></description><link>http://direct.ecency.com/hive-148441/@ikservices/august-30-2023-glomerular-hyperfiltration-and-sglt-2-inhibitors-in-early-diabetes</link><guid isPermaLink="true">http://direct.ecency.com/hive-148441/@ikservices/august-30-2023-glomerular-hyperfiltration-and-sglt-2-inhibitors-in-early-diabetes</guid><category><![CDATA[hive-148441]]></category><dc:creator><![CDATA[ikservices]]></dc:creator><pubDate>Thu, 31 Aug 2023 03:43:09 GMT</pubDate><enclosure url="https://images.ecency.com/p/2dk2RRM2dZ8gKjXsrozapsD83FxL3Xbyyi5LFttAhrXxr16mCe4arfLHesfTM27SGyiM5yfF4icKPdfF4QTP48G3C7vPm9Eso92gzaFwKy3eKeDWKCPN5DijgVk8jRrNjYgJNcaEwzXDTpX3k2u5a41zjm5g1LhGzV8xnPW7rn?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[August 28, 2023. SGLT-2 Inhibitors Lowers the Risk of Progression of CKD or Cardiovascular Death in Patients with CKD]]></title><description><![CDATA[Article name: Empagliflozin in Patients with Chronic Kidney Disease Link DOI This article was published in the New England Journal of Medicine in 2023. It is a randomized controlled trial which compared]]></description><link>http://direct.ecency.com/hive-163521/@ikservices/august-28-2023-sglt-2-inhibitors-lowers-the-risk-of-progression-of-ckd-or-cardiovascular-death-in-patients-with-ckd</link><guid isPermaLink="true">http://direct.ecency.com/hive-163521/@ikservices/august-28-2023-sglt-2-inhibitors-lowers-the-risk-of-progression-of-ckd-or-cardiovascular-death-in-patients-with-ckd</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[ikservices]]></dc:creator><pubDate>Tue, 29 Aug 2023 02:45:33 GMT</pubDate><enclosure url="https://images.ecency.com/p/2dk2RRM2dZ8gKjXsrozapsD83FxL3Xbyyi5LFttAhrXxr16mCe4arfLHesfTM27SGyiM5yfF4icKPdfF4QTP48G3C7vPm9Eso92gzaFwKy3eKeDWKCPN5DijgVk8jRrNjYgJNcaEwzXDTpX3k2u5a41zjm5g1LhGzV8xnPW7rn?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>